Omniscient Neurotechnology
PrivateLast Round
Series D
May 29, 2026
Est. Valuation
$295M
Total Funding Raised
$94.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Omniscient Neurotechnology is a healthcare technology company that offers a cloud-based connectomic analysis platform utilizing artificial intelligence to transform standard MRI scans into detailed brain network maps, facilitating the identification of neurological connections for improved patient care and predictive analytics.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniscient Neurotechnology Comparables
Compare Omniscient Neurotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainSightAI | 82% | |
| Sora Neuroscience | 80% | |
| Synaptive Medical | 78% |
Omniscient Neurotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 29, 2026 | ||||
| Pre Seed | Apr 3, 2026 | ||||
| Series C | Jun 11, 2024 | ||||
| Series B | Jul 19, 2021 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
Omniscient Neurotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MS&AD Ventures | Pre Seed |
| Anamcara Capital | Pre Seed |
| Plug and Play Tech Center | Pre Seed |
| Drysdale Ventures | Pre Seed |
| xdeck | Pre Seed |
| National Reconstruction Fund Corporation | Series D |
| OIF Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2026
$13.3M round completed.
- Apr 15, 2026
Neurological planning and visualization tool using resting-state fMRI has received FDA clearance.
Recent news
Latest coverage and updates
- launchesSep 11, 2026
Omniscient Neurotechnology Pty. launched Quicktome Deep Brain on Sep 11th '26.
Omniscient Neurotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Omniscient Neurotechnology's valuation, stock price, and market status.
Is Omniscient a public or private company?
Omniscient is a private company.
What is the current stock price of Omniscient?
Omniscient is a private company with no public stock price. No recent secondary market data is available.
How much is Omniscient worth (valuation)?
Valuation information for Omniscient is not publicly available.
Can I buy Omniscient stock?
Omniscient shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Omniscient's last funding round?
Omniscient's most recent funding round was Series D on May 29, 2026.
Who are the main investors in Omniscient?
Key investors in Omniscient include National Reconstruction Fund Corporation, OIF Ventures, Seedcamp.
Will Omniscient IPO soon?
No public IPO plans have been announced for Omniscient.
How can I track Omniscient secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omniscient's secondary market activity and sign up for updates.